Innovations in Oral Drug Delivery: Challenges and Opportunities


Year : 2025 | Volume : | | Page : –
    By

    Sudipta Roy,

  1. Associate Professor, Department of Pharmaceutics, Bengal College of Pharmaceutical Technology, Dubrajpur, West Bengal, India

Abstract

The advancement of novel drug manufacturing technologies offers immense opportunities for innovation but brings regulatory complexities that must be addressed to ensure successful implementation. Early and frequent collaboration with the FDA is fundamental for overcoming these challenges. The establishment of the FDA’s Emerging Technology Team has been pivotal in fostering open dialogue, brainstorming, and feedback between regulators and innovators, reducing the likelihood of unexpected setbacks that could jeopardize projects. Mechanisms to evaluate technologies outside individual product submissions, such as pilot programs for novel excipients, provide a framework for ensuring reproducibility and quality, while mitigating risks associated with untested approaches. Global regulatory harmonization is another critical area for improvement. The lack of alignment among jurisdictions often creates delays and increases costs, requiring companies to maintain multiple product versions until all approvals are secured. Programs like the European Mutual Recognition Procedure and FDA’s Project Orbis highlight the benefits of international cooperation in streamlining approval processes. For emerging technologies such as microparticles and nanoparticles, the development of standardized regulatory guidelines is essential to facilitate scalability, characterization, and public acceptance. Additionally, regulatory incentives, such as exclusivity periods and monograph development for novel excipients, could drive innovation and encourage broader adoption. Relaxing similarity requirements for generics and biosimilars may also enhance manufacturability and patient outcomes. By fostering collaboration, harmonizing international regulations, and proactively addressing gaps in guidance, stakeholders can accelerate the adoption of cutting-edge technologies, delivering high-quality, safe, and effective drug products to patients more efficiently.

Keywords: Drug Delivery, Microfabricated Devices, Extrusion-Based Methods, Lyophilization, Cancer Treatment via Oral Delivery.

How to cite this article:
Sudipta Roy. Innovations in Oral Drug Delivery: Challenges and Opportunities. Trends in Drug Delivery. 2025; ():-.
How to cite this URL:
Sudipta Roy. Innovations in Oral Drug Delivery: Challenges and Opportunities. Trends in Drug Delivery. 2025; ():-. Available from: https://journals.stmjournals.com/tdd/article=2025/view=196630


References

  1. Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023). Advances in Oral Drug Delivery Systems: Challenges and Opportunities. Pharmaceutics, 15(2), 484. https://doi.org/10.3390/pharmaceutics15020484
  1. Almansour, Mohammed A., et al. “Recent Innovations in Oral Drug Delivery Systems: Examining Current Challenges and Future Opportunities for Enhanced Therapeutic Efficacy.” International journal of health sciences, vol. 7, no. S1, 2023, pp. 3352-3370, doi:10.53730/ijhs.v7nS1.15041.
  2. Lorscheider, M., Gaudin, A., Nakhlé, J., Veiman, K. L., Richard, J., & Chassaing, C. (2020). Challenges and Opportunities in the Delivery of Cancer Therapeutics: Update on Recent Progress. Therapeutic Delivery, 12(1), 55–76. https://doi.org/10.4155/tde-2020-0079
  3. Benson HA, Roberts MS. Challenges and Innovations of Controlled Drug Delivery. Fundamentals of Drug Delivery. 2021 Oct 26:1-4 https://doi.org/10.1002/9781119769644.ch1 .
  4. Bhowmik D, Duraivel S, Kumar KS. Recent trends in challenges and opportunities in transdermal drug delivery system. The Pharma Innovation. 2012 Dec 1;1(10).
  5. Hamzy, Ibrahim A., et al. “Addressing the Challenges and Advancements in Oral Drug Delivery Systems for Biopharmaceuticals: A Comprehensive Review of Recent Developments and Future Directions.” International journal of health sciences, vol. 4, no. S1, 2020, pp. 132-153, doi:10.53730/ijhs.v4nS1.15095
  6. Kappelle, W. F. W., Siersema, P. D., Bogte, A., & Vleggaar, F. P. (2016). Challenges in oral drug delivery in patients with esophageal dysphagia. Expert Opinion on Drug Delivery, 13(5), 645–658. https://doi.org/10.1517/17425247.2016.1142971
  7. National Academies of Sciences, Engineering, and Medicine. Innovations in Manufacturing Drug Products. InInnovations in Pharmaceutical Manufacturing on the Horizon: Technical Challenges, Regulatory Issues, and Recommendations 2021 Feb 24. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK570316/
  8. Aliev ZM, Nersisyan MK, Denisova VV, Bigvava AZ, Luchkovskaya DI, Ermilin DR. The Use of Innovative Materials in the Organization of Clinical Treatment in Dentistry. Journal of Pharmaceutical Research International. 2021 Nov 20;33(51A):6-12.
  9. Hens B, Corsetti M, Spiller R, Marciani L, Vanuytsel T, Tack J, Talattof A, Amidon GL, Koziolek M, Weitschies W, Wilson CG. Exploring gastrointestinal variables affecting drug and formulation behavior: methodologies, challenges and opportunities. International Journal of Pharmaceutics. 2017 Mar 15;519(1-2):79-97 https://doi.org/10.1016/j.ijpharm.2016.11.063 .
  10. Mohammed A, Elshaer A, Sareh P, Elsayed M, Hassanin H. Additive manufacturing technologies for drug delivery applications. International Journal of Pharmaceutics. 2020 Apr 30;580:119245.
  11. Mishra AC, Chaubey R, Srivastava SP. Implementation of nanotechnology in healthcare: immense challenges and opportunities. Biological Sciences. 2022 Jul 29;2(3):251-61 DOI: https://doi.org/10.55006/biolsciences.2022.2303 .
  12. Chua, C.Y.X., Jimenez, M., Mozneb, M. et al. Advanced material technologies for space and terrestrial medicine. Nat Rev Mater 9, 808–821 (2024). https://doi.org/10.1038/s41578-024-00691-0
  13. George A, Shah PA, Shrivastav PS. Natural biodegradable polymers based nano-formulations for drug delivery: A review. International journal of pharmaceutics. 2019 Apr 20;561:244-64 https://doi.org/10.1016/j.ijpharm.2019.03.011 .
Ahead of Print Subscription Review Article
Volume
Received 17/01/2025
Accepted 28/01/2025
Published 01/02/2025
Visits: 31


Loading citations…